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Abstract
Background: Prader-Willi syndrome (PWS) is characterized by hypotonia, delayed neuropsychomotor development,
overeating, obesity and mental deficiency. This phenotype is encountered in other conditions, defining Prader-Willi-
like syndrome (PWLS).
Case presentation: We report a 14-year-old boy with a complex small supernumerary marker chromosome (sSMC)
associated with PWLS. The propositus presents clinical features commonly found in patients with PWLS, including
growth hormone deficit. Banding karyotype analysis and fluorescence in situ hybridization (FISH) revealed a marker
derived from chromosome 6 and a neocentromere as suspected, but array-CGH enabled us to characterize this
marker as a der(10)t(6;10)(6qter→ 6q23.3::10p11.1→ 10p11.21)dn. As far as we know, this is the first diagnosed case
of PWLS associated with a complex sSMC, involving a 30.9 Mb gain in the 6q16.3q23.3 region and a 3.5 Mb gain in
the 10p11.21p11.1 region. Several genes have been mapped to the 6q region including the TCBA1 gene, which is
associated with developmental delay and recurrent infections, the ENPP1 gene, associated with insulin resistance
and susceptibility to obesity and the BMIQ3 gene, associated with body mass index (BMI). No OMIM gene was
found in the smallest 10p11.21p11.1 region.
Conclusions: We suggest that the duplicated chromosome segment 6q16.3q23.3 may be responsible for the
phenotype of our case and may also be a candidate locus of PWLS.
Keywords: Complex sSMC, Array-CGH, Prader-Willi-like syndrome, 6q16.3q23.3
Background
Prader-Willi syndrome (PWS) is characterized by hypo-
tonia during the neonatal stage and in childhood, ac-
companied by delayed neuropsychomotor development
[1]. Overeating, obesity and mental deficiency arise later
on. In addition to obesity, Prader-Willi syndrome includes
several other endocrine disorders, such as hypothyroidism,
growth hormone deficiency, and hypogonadotropic hypo-
gonadism [1]. PWS is caused by a lack of expression of
genes located on paternal chromosome 15q11q13. This
lack of gene expression may be due to a deletion in this
chromosomal segment, to maternal uniparental disomy of
chromosome 15, or to a defect in the imprinting centre
on 15q11–15q13, or rarely with small supernumerary
marker chromosomes 15 (sSMC) [1]. Small supernumer-
ary marker chromosomes (sSMC) are structurally abnor-
mal chromosomes, generally equal in size to or smaller
than a chromosome 20 of the same metaphase spread,
that cannot be characterized by conventional banding
cytogenetics [2]. sSMC can have different shapes (ring-,
centric minute- and inverted duplication-shaped), and in
most cases consist of pericentric chromosomal material
[3]. They can originate from any part of human chromo-
somes to form neocentromeres [4]. sSMC are found in
0.043 % of new-borns and in 0.433 % of cases with
intellectual disability [5]. A number of other conditions
associate obesity and developmental disability. These
include UPD14, Cohen syndrome, Bardet-Biedl syndrome,
Alstrom syndrome, duplications of 3p25.3–p26.2 and of
Xq27.2-ter and deletions 1p36, 6q16 (SIM1), and 10q26
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[6]. A recent study by array-CGH in 100 children with
syndromic obesity showed new candidate genes (PLIN2,
CDH13, CNTNAP2, CPPED1, NDUFA4, PTGS2 and
SOCS6) and 22 % of patients with pathogenic or poten-
tially pathogenic CNVs were identified [7].
We report a boy with PWLS associated with a small
supernumerary marker chromosome (sSMC). This is
the first case of an sSMC involving chromosome 6 and
10 and was characterized as der(10)t(6;10)(6qter→
6q23.3::10p11.1→ 10p11.21)dn. To the best of our
knowledge, this is the first PWLS which could be due to
a complex sSMC.
Case presentation
The patient, a male, was born to healthy, non-
consanguineous parents and has 2 sisters. The heights of
the father and mother are 174 and 156 cm, respectively.
The patient was born at full term; his birth weight was
3610 g, length 52.5 cm, head circumference 35 cm. Sev-
eral respiratory tract infections were treated during his
first years of life and saturnism was diagnosed at 5 years
old, with no need for treatment. The patient had normal
psychomotor acquisition (walked at 16 months), devel-
opmental delay with school retardation and speech ar-
ticulation defects. At 15.5 years old (Fig. 1a), the patient
was 145.4 cm tall (−3.8SD), 55.3 kg in weight (BMI =
26.6 kg/m2 = +2.8SD: overweight according to WHO cri-
teria [8]) suffered from intellectual deficiency and could
neither read nor write. He had central obesity, small
hands and feet (Fig. 1b, c), short stature, pubertal delay
(small penis and testes), lower limb livedo, café-au-lait
spots on his neck and the facial features of Prader-Willi
syndrome. These observations were compatible with the
Prader-Willi-like phenotype [6, 9]. Bioassays showed iso-
lated GH deficiency with low IGF-I concentrations with
no evidence of hypothalamic-pituitary disease with nor-
mal MRI.
Methods
Blood samples of the patient and his parents were drawn
after informed consent had been obtained. Chromosome
analysis was performed on 72-h lymphocyte cultures ac-
cording to standard techniques [10]. Preparations were
GTG and RHG banded by standard procedures. Fluores-
cence in situ hybridization (FISH) was carried out using
octochrome cytocell® according to the manufacturer’s in-
structions (Cytocell Ltd, Cambridge, United Kingdom).
This kit combines an 8-square multiprobe device and
the whole chromosome painting probe (labelled in 3
different colours) to allow all 24 chromosomes to be
identified on a single slide. Array-CGH analysis was
performed according to the Agilent protocol with minor
protocol modifications using Agilent 4x180K [11].
Results
Conventional cytogenetic analysis on cultured T-
lymphocytes revealed a male karyotype with a small
supernumerary marker chromosome in 32 % of the cells
analysed: mos 47, XY,+mar[8]/46,XY[17] (Fig. 2). Paren-
tal karyotypes from peripheral blood lymphocytes were
both normal, indicating a de novo origin of the sSMC.
The karyotype after conventional cytogenetic analysis
and FISH (whole painting probe) can be described as:
mos 47,XY,+mar[8]/46,XY[17].ish neo(6)(wcp6+, D6Z1-,
Fig. 1 Phenotype of the patient at the age of 15 years. a. Note the central obesity, short stature, café-au-lait spots and facial features of Prader-Willi.
b and c. Small hands and feet
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tel6p-, tel6q-)dn. Array-CGH analysis confirmed the du-
plicated region of chromosome 6 (Fig. 3a): 6q16.3q23.3
(102,474,305-133,386,766) of 30.9 Mb that included the
153 genes previously observed in FISH and showed a dupli-
cated pericentromeric region 10p11.21p11.1 (35,490,990-
39,076,732) (GRCh37/hg19) of 3.5 Mb that included 7
genes (Fig. 3b). The duplicated region of chromosome 10
was confirmed by another centromere FISH of chromo-
some 10 (Fig. 4). The resulting karyotype associated with
array-CGH analysis can be described as 47,XY,+ der
(10)t(6;10)(6qter→ 6q23.3::10p11.1→ 10p11.21)dn arr[hg1
9]6q16.3q23.3(102,474,305-133,836,766)×2 ~ 3,10p11.21p1
1.1(35,490,990-39,076,732)×2 ~ 3. Array-CGH mosaicism
of chromosome 10 and chromosome 6 was estimated at
about 25.0 % (log2 ratio: 0.14). The mosaicism rate found
with array-CGH analysis was similar to that found with
karyotyping. Maternal uniparental disomy of chromosome
15 was ruled out (data not shown).
Discussion
To the best of our knowledge, this is the first report of a
patient with PWLS associated with a complex sSMC,
which involved chromosome 6 and 10 at breakpoints of
6q16.3q23.3 and 10p11.21p11.1, respectively. Complex
small supernumerary marker chromosomes (sSMC) are
a subgroup of sSMC derived from more than one
chromosome [2]. The Liehr sSMC database [12] has
collected approximately 412 cases of complex sSMC
from the literature, which represent 8.4 % of all sSMC
cases [4]. The majority of complex sSMC cases are
der(22)t(11;22)(q23;q11.2) or Emanuel syndrome cases
(339/412 cases; 82 %) and present generally in banding
cytogenetics as centric minutes [3]. Among the 73 com-
plex sSMC described by Liehr T. excluding Emanuel
syndrome, 64 % were inherited from a balanced trans-
location in one parent (83 % maternally derived) [3] and
10 % were in mosaic. All of the human chromosomes,
except chromosome 10, have already been shown to be
involved in complex sSMC [3].
To investigate whether the duplicated 6q16.3q23.3 and
10p11.21p11.1 regions could play a role in PWL syn-
drome, all cases with comparable chromosome 6q and
10p duplications documented in PubMed, the sSMC
Liehr database [12] and DECIPHER [13] were reviewed.
Duplications of the 6q16.3q23.3 region are rare and no
similar cases with sSMC comprising the 6q16.3q23.3 re-
gion have ever been described in the literature [12, 14].
Two cases with 6q16.3q23.3 duplications are reported in
the DECIPHER database [13] (available from http://deci-
pher.sanger.ac.uk and via email from decipher@sanger.
ac.uk.) with the phenotype: case 4145 (7 Mb duplication)
with brachycephaly, epicanthus, intellectual disability,
intrauterine growth retardation, muscular hypotonia and
ptosis; case 2068365 (2.3 Mb duplication) with hydro-
cephalus, macrocephaly and parietal foramina. Three
cases with 6q21q23 duplications were described only at
the cytogenetic level and associated with developmental
delay, congenital hearts defects, depressed nasal bridge
and epicanthal folds [15, 16] and two cases of 6q21q22.1
in a mother and her daughter showed similar phenotypes
(cognitive difficulties, obesity, essential tremor) and café-
au-lait spots in the daughter [17]. Regarding other regions
of 6q chromosome, trisomy 6qter has also been associated
with mental retardation and obesity starting from child-
hood [18, 19], but cases of neocentric sSMC (6q) pheno-
types show no similarity to ours [12, 20, 21]. Our patient’s
complex sSMC involves chromosome 10 too and it is, to
the best of our knowledge, the first report of a complex
sSMC involving chromosome 10 and characterized by
array-CGH. All human chromosomes have already been
included in a complex sSMC except for chromosome 10.
Fig. 2 sSMC on Karyotype RHG and GTG banding
Fig. 3 Result of the array-CGH genotyping (GRCh37/hg19) of the genomic gain, originating from chromosome 6 (a) and 10 (b). a. The array-CGH
showed a 30.9 Mbp gain in the 6q16.3 - q23.2 region (b). The array-CGH showed a 3.5 Mbp gain in the 10p11.21 - p11.1 region
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The pericentromeric region of chromosome 10 is known
to comprise many copy number variations and other
repetitive elements [22]. In our case, the OMIM gene map
search [23] for the duplicated 10p11.21p11.1 region
revealed no disease-causing genes.
A total of 60 CNVs have been found in 100 patients
with syndromic obesity in a recent study [7] using array-
CGH and can be classified into three groups: the first
was considered clinically relevant for syndromic obesity
(n = 14), the second potentially relevant (n = 17) and the
third probably benign (n = 29). The second group with
potentially clinically relevant CNVs (inherited from one
parent with an abnormal phenotype) contained genes of
particular interest involved in insulin or adiponectin re-
ceptor and peroxisomal acid metabolism: SOC6, PLIN2,
CDH13, CNTNAP2, SOX3 and ACOXL.
The OMIM gene map search [23] of the duplicated
6q16.3q23.3 region revealed more than 150 genes in-
cluding TCBA1, BMIQ3 and ENPP1 genes. Two bal-
anced translocations showed that the TCBA1 (NKAIN2;
Na+/K+ transporting ATPase-Interacting Protein 2) gene
was truncated in 1 patient with a severe neurological
phenotype (epileptic encephalopathy with spastic tetrapar-
esis and severe psychomotor retardation, microcephaly,
hand dysmorphism and hypogonadism with micropenis
and cryptorchidism), and a second patient with develop-
mental delay and recurrent infections [24, 25]. These two
de novo translocations provide evidence that constitu-
tional inactivation (haploinsufficiency) of the TCBA1 gene
causes developmental delay and a distinct phenotype.
BMIQ3 was linked with body mass index (BMI) using a
genome-wide linkage analysis [26] using polymorphic
markers and LOD scores. In the same way, ENPP1 was
associated with insulin resistance and susceptibility to
obesity [27]. Moreover, Prader-Willi-like syndrome with
growth hormone deficit has been described with 6q16.1–
q21deletions [28, 29] and associated with Single-minded 1
gene (SIM1) at 6q16.2 [30] and/or POU3F2 (BRN2) at
6q16.1 [29]. However the SIM1 and POU3F2 genes were
not included in the duplicated 6q16.3q23.2 region of
our patient.
Conclusions
According to these data and a review of the literature,
our patient’s phenotype seems to be related to the eu-
chromatin of chromosome 6 rather than chromosome
10. The duplicated 6q16.3q23.3 may be a candidate locus
of PWLS with TCBA1 as the candidate gene for mental
retardation and BMIQ3 and ENPP1 implicated in the
susceptibility to obesity. This case illustrates the import-
ance of array-CGH to characterize more precisely sSMC
not elucidated by FISH, and suggests that all neocentro-
mere markers detected by karyotype must by analysed
by array-CGH.
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